Jayson Bedford
Stock Analyst at Raymond James
(3.79)
# 718
Out of 5,122 analysts
324
Total ratings
53.42%
Success rate
7.36%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $34.22 | -21.10% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $478.49 | +26.02% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $20.15 | -5.71% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $108.20 | +34.94% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $234.47 | -10.86% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $88.09 | +28.28% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $149.98 | +20.02% | 22 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $79.37 | +28.51% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $70.82 | +44.03% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $75.50 | +64.24% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $251.24 | +43.29% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $136.62 | +35.41% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $207.87 | +29.89% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.49 | -4.67% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $106.00 | +155.66% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.15 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.99 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $79.77 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.03 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $101.84 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.23 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.59 | +15.30% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.39 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.08 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $34.22
Upside: -21.10%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $478.49
Upside: +26.02%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $20.15
Upside: -5.71%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $108.20
Upside: +34.94%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $234.47
Upside: -10.86%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $88.09
Upside: +28.28%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $149.98
Upside: +20.02%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $79.37
Upside: +28.51%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $70.82
Upside: +44.03%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $75.50
Upside: +64.24%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $251.24
Upside: +43.29%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $136.62
Upside: +35.41%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $207.87
Upside: +29.89%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.49
Upside: -4.67%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $106.00
Upside: +155.66%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.15
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.99
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $79.77
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.03
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $101.84
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.23
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.59
Upside: +15.30%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.39
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $11.08
Upside: -